Thioglycolic Acid

Thioglycolic Acid

SCHEMBL2720474

O=C(O)CS.O=C(O)CS.O=C(O)CS.O=C(O)CS.O=C(O)CS.O=C(O)CS.OCC(CO)(CO)CO

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 5/20 0.33
FOLH1 Q04609 4/20 0.33
ANPEP P15144 3/20 0.33
ALDH1A1 P00352 3/20 0.33
TSHR P16473 2/20 0.33
ACE P12821 1/20 0.32
LDHA P00338 1/20 0.32
SRR Q9GZT4 1/20 0.32
LMNA P02545 1/20 0.32
ALKBH5 Q6P6C2 1/20 0.32
SUCNR1 Q9BXA5 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
MAPK1 P28482 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
HIF1A Q16665 1/20 0.31
GSTK1 Q9Y2Q3 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thioglycolic Acid SCHEMBL6679887 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL10489543 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL538077 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL538389 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL331393 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL60562 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL99587 1.00 ENPEP (0.33) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL31042705 0.97 ENPEP (0.32) ENPEPFOLH1ANPEPALDH1A1TSHR
Glycolic Acid SCHEMBL27550333 0.94 ALDH1A1 (0.32) ENPEPFOLH1ANPEPALDH1A1TSHR
Thioglycolic Acid SCHEMBL30056598 0.92 FFAR3 (0.37) ENPEPFOLH1ANPEPTSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10093762-B2 Process for modifying polymers AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2018-10-09 US claimed
US-20180155480-A1 PROCESS FOR MODIFYING POLYMERS WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT (GB) 2018-06-07 US claimed
EP-3286253-A1 PROCESS FOR MODIFYING POLYMERS Akzo Nobel Chemicals International B.V. (NL) 2018-02-28 EP claimed
WO-2016170018-A1 PROCESS FOR MODIFYING POLYMERS AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2016-10-27 WO claimed
US-10093762-B2 Process for modifying polymers AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2018-10-09 US disclosed
US-20180155480-A1 PROCESS FOR MODIFYING POLYMERS WILMINGTON TRUST (LONDON) LIMITED, AS COLLATERAL AGENT (GB) 2018-06-07 US disclosed
EP-3286253-A1 PROCESS FOR MODIFYING POLYMERS Akzo Nobel Chemicals International B.V. (NL) 2018-02-28 EP disclosed
WO-2016170018-A1 PROCESS FOR MODIFYING POLYMERS AKZO NOBEL CHEMICALS INTERNATIONAL B.V. (NL) 2016-10-27 WO disclosed
EP-2760947-B1 INKJET INK COMPOSITION AND INKJET RECORDING METHOD FUJIFILM CORP (JP) 2015-11-04 EP disclosed
US-8939543-B2 Inkjet ink composition and inkjet recording method FUJIFILM CORPORATION (JP) 2015-01-27 US disclosed
US-8846017-B2 Cosmetic compositions comprising at least one cationic copolymer and at least one amino silicone and methods of use thereof L'OREAL (FR) 2014-09-30 US disclosed
EP-2760947-A2 INKJET INK COMPOSITION AND INKJET RECORDING METHOD FUJIFILM Corporation (JP) 2014-08-06 EP disclosed
US-20090074699-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE AMINO SILICONE AND METHODS OF USE THEREOF L'OREAL S.A. (FR) 2009-03-19 US disclosed
US-20090074692-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE ANIONIC ASSOCIATIVE POLYMER AND COSMETIC TREATMENT PROCESSES USING SAID COMPOSITION L'OREAL S.A. (FR) 2009-03-19 US disclosed
US-20090074698-A1 COSMETIC COMPOSITIONS CONTAINING AT LEAST ONE CATIONIC COPOLYMER, AT LEAST ONE CYCLODEXTRIN AND AT LEAST ONE SURFACTANT, AND USES THEREOF L'OREAL S.A. (FR) 2009-03-19 US disclosed
US-20090074695-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC COPOLYMER, AT LEAST ONE AMINO SILICONE AND AT LEAST ONE CATIONIC POLYMER, AND METHODS OF USE THEREOF L'OREAL S.A. (FR) 2009-03-19 US disclosed
US-20090074696-A1 COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER AND A STARCH AND COSMETIC TREATMENT PROCESS THEREOF L'OREAL S.A. (FR) 2009-03-19 US disclosed
US-20090074690-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE TRIGLYCERIDE AND METHODS OF USE THEREOF L'OREAL S.A. (FR) 2009-03-19 US disclosed
EP-1987082-A1 SUBTITUTED ORGANOPOLYSILOXANES AND USE THEREOF Phosphonics Ltd. (GB) 2008-11-05 EP disclosed
WO-2007090676-A1 SUBTITUTED ORGANOPOLYSILOXANES AND USE THEREOF PHOSPHONICS LTD (GB) 2007-08-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090074692-A1 COSMETIC COMPOSITION COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE ANIONIC ASSOCIATIVE POLYMER AND COSMETIC TREATMENT PROCESSES USING SAID COMPOSITION PHOSPHO1, CUTA, VMP1 ENPEP 2535/4885FOLH1 2630/4885ANPEP 4363/4885
US-20090074699-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE AMINO SILICONE AND METHODS OF USE THEREOF KRT18, CUTA, C1R ENPEP 1888/4885FOLH1 3623/4885ANPEP 1561/4885
US-20090074696-A1 COSMETIC COMPOSITION COMPRISING A CATIONIC COPOLYMER AND A STARCH AND COSMETIC TREATMENT PROCESS THEREOF TYR, OXGR1, OGFOD1 ENPEP 3301/4885FOLH1 3845/4885ANPEP 3909/4885
US-20090074690-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC COPOLYMER AND AT LEAST ONE TRIGLYCERIDE AND METHODS OF USE THEREOF SGMS1, KRT18, H1-10 ENPEP 4421/4885FOLH1 4549/4885ANPEP 4103/4885
US-20090074698-A1 COSMETIC COMPOSITIONS CONTAINING AT LEAST ONE CATIONIC COPOLYMER, AT LEAST ONE CYCLODEXTRIN AND AT LEAST ONE SURFACTANT, AND USES THEREOF C1R, DSC1, CDYL ENPEP 4458/4885FOLH1 4519/4885ANPEP 4101/4885
US-20090074695-A1 COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE CATIONIC COPOLYMER, AT LEAST ONE AMINO SILICONE AND AT LEAST ONE CATIONIC POLYMER, AND METHODS OF USE THEREOF H1-0, H1-10, KRT18 ENPEP 4026/4885FOLH1 4230/4885ANPEP 3396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.